Physiological and pathophysiological actions of insulin in the liver
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
The liver plays an important role in the control of glucose homeostasis. When insulin levels are low, such as in the fasting state, gluconeogenesis and glycogenolysis are stimulated to maintain the blood glucose levels. Conversely, in the presence of increased insulin levels, such as after a meal, synthesis of glycogen and lipid occurs to maintain the blood glucose levels within normal range. Insulin receptor signaling regulates glycogenesis, gluconeogenesis and lipogenesis through downstream pathways such as the insulin receptor substrate (IRS)-phosphoinositide 3 (PI3) kinase-Akt pathway. IRS-1 and IRS-2 are abundantly expressed in the liver and are thought to be responsible for transmitting the insulin signal from the insulin receptor to the intracellular effectors involved in the regulation of glucose and lipid homeostasis. Impaired insulin receptor signaling can cause hepatic insulin resistance and lead to type 2 diabetes. In the present study, we focus on a concept called "selective insulin resistance," which has received increasing attention recently: the frequent coexistence of hyperglycemia and hepatic steatosis in people with type 2 diabetes and obesity suggests that it is possible for the insulin signaling regulating gluconeogenesis to be impaired even while that regulating lipogenesis is preserved, suggestive of selective insulin resistance. In this review, we review the progress in research on the insulin actions and insulin signaling in the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The concept of hepatic zonation of insulin signaling components can also help explain the paradoxical coexistence of increased hepatic glucose output and increased hepatic lipogenesis in MASLD [15,20].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Activation of NFκB promotes further inflammatory gene expressions [83, 84] and inhibits insulin signaling through serine phosphorylation of IRS-1 or other insulin signaling molecules, leading to hepatic insulin resistance [85, 86].”
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“Although several isoforms of IRS have been identified, including IRS-1, -2, -3, -4, -5, and -6 [9, 10, 16-19], IRS-1 and IRS-2 constitute the main IRS iso‐ forms expressed in the liver [20-22]; IRS-6 is almost not detectable at all in the liver [19].”
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 1×
“Glycogen synthase kinase-3 (GSK3) β is reported to play an important role in the regulation of insulin-induced glycogen synthesis [36, 37].”
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 2×
“Insulin receptor signaling through pathways downstream of the insulin receptor, such as the insulin receptor substrate (IRS)-phosphoinositide 3 (PI3) kinase-Akt pathway, is known to regulate glycogenesis, gluconeogenesis, and lipogenesis [7].”
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 1×
“In addition to direct regulation of the expres‐ sions of gluconeogenic genes by FoxO1, peroxisome proliferator-activated receptor-γ coactivator (PGC)1α, a transcription coactivator, is also a major regulator of the expressions of gluconeogenic genes [59, 60].”
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574 · cited 2×
“Especially, IRS-1 and IRS-2 are abundantly expressed in the liver [8-10] and are thought to be responsible for transmitting the insulin signal from the insulin receptor to the intracellu‐ lar effectors involved in the regulation of glucose and lipid homeostasis.”
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555 · cited 1×
“…2 in the TSC1/TSC2 complex, and in turn, the phosphorylated TSC1/TSC2 complex reduces the GTPase activity of Rheb, causing activation of mTORC1 [55, 56]. mTORC1 increases the phosphorylation of 4EBP1 and S6K1, which results in increased protein synthesis and cell pro‐ liferation via activation of…”
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 2×
“FoxO1 is localized in the nucleus, where it directly binds to the promoters of gluconeogenic genes, such as those encoding glucose 6-phosphatase ( G6Pase ) and phos‐ phoenol pyruvate carboxykinase ( PEPCK ), activating glucose production [44, 45].”
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035
The interaction of hepatic lipid and glucose metabolism in liver diseases
Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamisligil, G. S., Trauner, M., & Canbay, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.025 · Cited by 994
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Enzymes of triacylglycerol synthesis and their regulation
Coleman, R. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00051-1 · Cited by 965
Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F., & Birnbaum, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100462200 · Cited by 959
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935
Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene
Chen, W. S., Xu, P.-Z., Gottlob, K., Chen, M.-L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K., et al. (2001) · Genes & Development · doi:10.1101/gad.913901 · Cited by 928
Self-citationHypothalamic insulin signaling is required for inhibition of glucose production
Obici, S., Zhang, B. B., Karkanias, G., & Rossetti, L. (2002) · Nature Medicine · doi:10.1038/nm1202-798 · Cited by 904 · cited 1×
“Central administration of insulin has been demonstrated to inhibit HGP via activation of the K ATP channel and consequently regulation of autonomic out‐ flow to the liver [69-71].”
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., Ruiter, N. D. D., De Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 882
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 793
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771 · cited 1×
“…reported to be inversely correlated with hepatic and whole-body insulin sensitivity and directly correlated with the plasma insulin concentrations [114], it is possible that enhanced hepatic insulin signaling resulting from hyperinsulinemia in cases of MASLD might directly promote hepatic de novo…”
Foretz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 747
Shimano, H., Horton, J. D., Shimomura, I., Hammer, R. E., Brown, M. S., & Goldstein, J. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119248 · Cited by 730
Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16885 · Cited by 726 · cited 1×
“In contrast, Akt2-deficient mice show insulin resistance, mild glucose intolerance, and mild growth deficiency [32, 33].”
Shimomura, I., Bashmakov, Y., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 708
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig, A., Jimenez-Liñan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B., Flier, J. S., & Moller, D. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118703 · Cited by 655
Hypothalamic KATP channels control hepatic glucose production
Pocai, A., Lam, T. K. T., Gutierrez-Juarez, R., Obici, S., Schwartz, G. J., Bryan, J., Aguilar-Bryan, L., & Rossetti, L. (2005) · Nature · doi:10.1038/nature03439 · Cited by 645
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620
Yu, S., Matsusue, K., Kashireddy, P., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210062200 · Cited by 619
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 615
Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
REGULATION OF GLUCOSE PRODUCTION BY THE LIVER
Nordlie, R. C., Foster, J. D., & Lange, A. J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.379 · Cited by 585
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2
George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 559
Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., & Unterman, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17184 · Cited by 540
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531
FoxO1 Regulates Multiple Metabolic Pathways in the Liver
Zhang, W., Patil, S., Chauhan, B., Guo, S., Powell, D. R., Le, J., Klotsas, A., Matika, R., Xiao, X., Franks, R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600272200 · Cited by 516
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 1×
“Increased DAG activates PKC, which phosphorylates the serine residues in the β-subunit of the insulin receptor, resulting in impairment of the insulin receptor interaction with sig‐ naling proteins downstream, including IRS-1 and IRS-2 [83, 93, 94].”
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
Dong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · cited 1×
“…previously generated by us and other groups also exhibited severely impaired glucose tolerance and insulin resistance with hyperinsulinemia [63, 64], and indeed, HGP was significantly higher in the LIRS1/2DKO mice; consistent with this finding, the hepatic G6Pase and PEPCK expression levels…”
Role of the liver in the control of carbohydrate and lipid homeostasis
Postic, C., Dentin, R., & Girard, J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70133-7 · Cited by 448
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Self-citationReply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Lazarus, J. V., Newsome, P. N., Francque, S. M., Kanwal, F., Terrault, N. A., & Rinella, M. E. (2024) · Hepatology · doi:10.1097/hep.0000000000000696 · Cited by 438
Matsumoto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27047 · Cited by 436
SREBP-1c Transcription Factor and Lipid Homeostasis: Clinical Perspective
Ferré, P., & Foufelle, F. (2007) · Hormone Research in Paediatrics · doi:10.1159/000100426 · Cited by 400
Ueki, K., Kondo, T., Tseng, Y.-H., & Kahn, C. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402511101 · Cited by 384
Yahagi, N., Shimano, H., Hasty, A. H., Matsuzaka, T., Ide, T., Yoshikawa, T., Amemiya-Kudo, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201584200 · Cited by 370
Schaeffler, A., Gross, P., Buettner, R., Bollheimer, C., Buechler, C., Neumeier, M., Kopp, A., Schoelmerich, J., & Falk, W. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02892.x · Cited by 360
Pettinelli, P., & Videla, L. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2129 · Cited by 351
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 344
Increased expression of PPARγ in high fat diet-induced liver steatosis in mice
Inoue, M., Ohtake, T., Motomura, W., Takahashi, N., Hosoki, Y., Miyoshi, S., Suzuki, Y., Saito, H., Kohgo, Y., & Okumura, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.070 · Cited by 340
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Jornayvaz, F. R., & Shulman, G. I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.005 · Cited by 317
New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin
Lawrence, J. C., & Roach, P. J. (1997) · Diabetes · doi:10.2337/diab.46.4.541 · Cited by 311
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production
Inoue, H., Ogawa, W., Asakawa, A., Okamoto, Y., Nishizawa, A., Matsumoto, M., Teshigawara, K., Matsuki, Y., Watanabe, E., Hiramatsu, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.009 · Cited by 294
Zhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707060104 · Cited by 291 · cited 1×
“Increased DAG activates PKC, which phosphorylates the serine residues in the β-subunit of the insulin receptor, resulting in impairment of the insulin receptor interaction with sig‐ naling proteins downstream, including IRS-1 and IRS-2 [83, 93, 94].”
Werman, A., Hollenberg, A., Solanes, G., Bjørbæk, C., Vidal-Puig, A. J., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20230 · Cited by 282
Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance
Leavens, K. F., Easton, R. M., Shulman, G. I., Previs, S. F., & Birnbaum, M. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.004 · Cited by 281
Taniguchi, C. M., Kondo, T., Sajan, M., Luo, J., Bronson, R., Asano, T., Farese, R., Cantley, L. C., & Kahn, C. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.005 · Cited by 279
Hepatic triacylglycerol accumulation and insulin resistance
Nagle, C. A., Klett, E. L., & Coleman, R. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800053-jlr200 · Cited by 272
Musso, C., Cochran, E., Moran, S. A., Skarulis, M. C., Oral, E. A., Taylor, S., & Gorden, P. (2004) · Medicine · doi:10.1097/01.md.0000133625.73570.54 · Cited by 264
Taylor, R., Magnusson, I., Rothman, D. L., Cline, G. W., Caumo, A., Cobelli, C., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118379 · Cited by 258
(2006) · doi:10.1016/j.tem.2006.01.005 · Cited by 256
Kubota, N., Kubota, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Mineyama, T., Ogata, H., Tokuyama, K., Ohsugi, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.007 · Cited by 244 · cited 3×
“The expression levels of SREBP1c and GK were signifi‐ cantly decreased in the livers of the LIRS1/2DKO mice [63].”
InfluentialSelf-citationBoj, S. F., van Es, J. H., Huch, M., Li, V. S. W., José, A., Hatzis, P., Mokry, M., Haegebarth, A., van den Born, M., Chambon, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.053 · Cited by 237
Mouse Models of Insulin Resistance
NANDI, A., KITAMURA, Y., KAHN, C. R., & ACCILI, D. (2004) · Physiological Reviews · doi:10.1152/physrev.00032.2003 · Cited by 231
Two New Substrates in Insulin Signaling, IRS5/DOK4 and IRS6/DOK5
Cai, D., Dhe-Paganon, S., Melendez, P. A., Lee, J., & Shoelson, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212430200 · Cited by 218
Brodbeck, D., Cron, P., & Hemmings, B. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9133 · Cited by 204
Newgard, C. B., Brady, M. J., O'Doherty, R. M., & Saltiel, A. R. (2000) · Diabetes · doi:10.2337/diabetes.49.12.1967 · Cited by 189 · cited 1×
“Insulin also activates GS by stimulating compartmentalized acti‐ vation of protein phosphatase 1 (PP1) in an Akt-GSK3β-independent manner [38, 39].”
Insulin Receptor Substrate 3 Is Not Essential for Growth or Glucose Homeostasis
Liu, S. C. H., Wang, Q., Lienhard, G. E., & Keller, S. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.18093 · Cited by 188
Nakatani, K., Sakaue, H., Thompson, D. A., Weigel, R. J., & Roth, R. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0559 · Cited by 187
Hales, E. C., Taub, J. W., & Matherly, L. H. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.021 · Cited by 187
Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18816 · Cited by 178
Wnt Signaling Regulates Hepatic Metabolism
Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., Lu, T., Bao, J., Han, D., Sack, M. N., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001249 · Cited by 174
Kubota, T., Kubota, N., & Kadowaki, T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.004 · Cited by 169
Self-citationGastaldelli, A., Toschi, E., Pettiti, M., Frascerra, S., Quiñones-Galvan, A., Sironi, A. M., Natali, A., & Ferrannini, E. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1807 · Cited by 168
Mora, M. V., Scarfone, A., Calvani, M., Greco, A. V., & Mingrone, G. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719326 · Cited by 148
Kubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12977 · Cited by 143 · cited 2×
“We previously identified that hepatic zona‐ tion of IRS-1 plays a crucial role in selective insulin resistance [115].”
Self-citationAkt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin
Altomare, D. A., Lyons, G. E., Mitsuuchi, Y., Cheng, J. Q., & Testa, J. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201750 · Cited by 138
The Insulin Receptor - A Critical Link in Glucose Homeostasis and Insulin Action
Patti, M., & Kahn, C. R. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.89 · Cited by 138
Hypothalamic insulin signaling is required for inhibition of glucose production
Obici, S., Zhang, B. B., Karkanias, G. B., et al. (2002) · Nature Medicine · doi:10.1038/nm798 · Cited by 138
Fritsche, L., Weigert, C., Häring, H., & Lehmann, R. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784534956 · Cited by 137
The dual function of hepatic SOCS3 in insulin resistance in vivo
Torisu, T., Sato, N., Yoshiga, D., Kobayashi, T., Yoshioka, T., Mori, H., Iida, M., & Yoshimura, A. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01044.x · Cited by 133
Aberrant Forkhead Box O1 Function Is Associated with Impaired Hepatic Metabolism
Qu, S., Altomonte, J., Perdomo, G., He, J., Fan, Y., Kamagaté, A., Meseck, M. L., & Dong, H. H. (2006) · Endocrinology · doi:10.1210/en.2006-0541 · Cited by 132
Insulin receptor internalization and signalling
Guglielmo, G. M. D., Drake, P. G., Baass, P. C., Authier, F., Posner, B. I., & Bergeron, J. J. M. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5647-3_6 · Cited by 131
Temporal Coding of Insulin Action through Multiplexing of the AKT Pathway
Kubota, H., Noguchi, R., Toyoshima, Y., Ozaki, Y.-I., Uda, S., Watanabe, K., Ogawa, W., & Kuroda, S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.018 · Cited by 128
Rahimian, R., Masih‐Khan, E., Lo, M., van Breemen, C., McManus, B. M., & Dubé, G. P. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1011927113563 · Cited by 127
Signalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127
Ayala, J. E., Streeper, R. S., Desgrosellier, J. S., Durham, S. K., Suwanichkul, A., Svitek, C. A., Goldman, J. K., Barr, F. G., Powell, D. R., & O’Brien, R. M. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1885 · Cited by 124
Okamoto, H., Obici, S., Accili, D., & Rossetti, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523096 · Cited by 122
Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats.
Kim, Y. B., Peroni, O. D., Franke, T. F., & Kahn, B. B. (2000) · Diabetes · doi:10.2337/diabetes.49.5.847 · Cited by 121
Atypical protein kinase C in insulin action and insulin resistance
Farese, R. V., Sajan, M. P., & Standaert, M. L. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330350 · Cited by 114
Akt isoforms and glucose homeostasis – the leptin connection
Hay, N. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.09.003 · Cited by 113
The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns
Noguchi, R., Kubota, H., Yugi, K., Toyoshima, Y., Komori, Y., Soga, T., & Kuroda, S. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.19 · Cited by 108
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0062-9 · Cited by 108 · cited 1×
“Conversely, FAS expression did not decrease in cases of MASLD despite the downregulation of IRS-2; rather, it showed a strong correlation with the IRS-1 expression [117].”
Cloning, Tissue Expression, and Chromosomal Localization of the Mouse IRS-3 Gene
Sciacchitano, S., & Taylor, S. I. (1997) · Endocrinology · doi:10.1210/endo.138.11.5518 · Cited by 103
Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
Altomare, D., Guo, K., Cheng, J., Sonoda, G., Walsh, K., & Testa (1995) · PubMed · Cited by 98
Regulation of the Fatty Acid Synthase Promoter by Insulin
Sul, H. S., Latasa, M.-J., Moon, Y., & Kim, K. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.315s · Cited by 89
Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli, P., Obregón, A. M., & Videla, L. A. (2011) · PubMed · doi:10.1590/s0212-16112011000300003 · Cited by 85
Cloning, Tissue Expression, and Chromosomal Location of the Mouse Insulin Receptor Substrate 4 Gene
Fantin, V. R. (1999) · Endocrinology · doi:10.1210/en.140.3.1329 · Cited by 77
New insights into the role and mechanism of glycogen synthase activation by insulin
Lawrence, J. C., & Roach, P. J. (1997) · Diabetes · doi:10.2337/diabetes.46.4.541 · Cited by 73
Effects of free fatty acids on gluconeogenesis and glycogenolysis
Boden, G. H. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02350-0 · Cited by 60
SnapShot: Insulin Signaling Pathways
Kadowaki, T., Ueki, K., Yamauchi, T., & Kubota, N. (2012) · Cell · doi:10.1016/j.cell.2012.01.034 · Cited by 56
Self-citationThe Liver and Glycogen: In Sickness and in Health
Soon, G. S. T., & Torbenson, M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076133 · Cited by 54
Insulin's effect on the liver: "Direct or indirect?" continues to be the question
Girard, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27743 · Cited by 47
Garofalo, R. S., Orena, S., Rafidi, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316885 · Cited by 40
Cloning, Tissue Expression, and Chromosomal Localization of the Mouse IRS-3 Gene
Sciacchitano, S. (1997) · Endocrinology · doi:10.1210/en.138.11.4931 · Cited by 35
Hypothalamic Control of Hepatic Glucose Production and Its Potential Role in Insulin Resistance
Buettner, C., & Camacho, R. C. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.09.001 · Cited by 34
Ito, Y., Vogt, P. K., & Hart, J. R. (2017) · Oncotarget · doi:10.18632/oncotarget.19866 · Cited by 27
Hoshiba, T., Kawazoe, N., & Chen, G. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110274 · Cited by 20
New concept in fatty liver diseases
Tokushige, K. (2023) · Hepatology Research · doi:10.1111/hepr.14004 · Cited by 20
Cited by
Truong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“Insulin receptor substrate 1 (IRS1) and IRS2 among IRS1–6 are the main adaptor proteins in the liver, activating phosphatidylinositol-3 kinase (PI3K) [9,11,15,19].”
InfluentialAccacha, S. D., Barillas, J., Srivastava, A., Ross, F., Drewes, W., Gulkarov, S., Leon, J. D., & Reiss, A. B. (2025) · Metabolites · doi:10.3390/metabo15050287 · Cited by 39
“In the liver, the main mediators of insulin signaling are insulin receptor substrate 1 (IRS1) and insulin receptor substrate 2 (IRS2) [61].”
Quercetin as an Anti-Diabetic Agent in Rodents—Is It Worth Testing in Humans?
Szkudelski, T., Szkudelska, K., & Łangowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157391 · Cited by 4
“However, quercetin therapy restored PEPCK activity to normal levels [32,99].”
InfluentialYang, Q., Xu, Y., Zhang, J., Xiao, N., Lu, H., Chen, B., Yang, B., Xie, Z., & Li, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1794782 · Cited by 6
“This results in hypergluconeogenesis and fasting hyperglycemia (85, 86).”
Nhau, P. T., Gamede, M. W., Khathi, A., & Sibiya, N. H. (2025) · Pathophysiology · doi:10.3390/pathophysiology32030039 · Cited by 3
Metadata
- Authors
- Kubota, N., Kubota, T., & Kadowaki, T.
- Affiliations
- Kumamoto University (JP)
- The Institute of Medical Science, Asahi Life Foundation (JP)
- Toranomon Hospital (JP)
- Corresponding author
- Kubota, Naoto
- Venue
- Endocrine Journal
- Publisher
- Japan Endocrine Society
- Published
- 2025
- Volume
- 72
- Issue
- 2
- Pages
- 149-159
- ISSN
- 0918-8959 (ISSN-L)
- 1348-4540
- PMC
- PMC11850106
- OpenAlex
- W4402120026
- Cited by
- 19
- References
- 115
- Citations by year
- 2026: 12 · 2025: 7
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Endocrine Journal (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (24K02500)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin signaling, liver, glucose homeostasis, gluconeogenesis, glycogen synthesis, lipogenesis, hepatic insulin resistance, insulin receptor substrate, PI3K/Akt signaling, type 2 diabetes, hepatic steatosis, obesity
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Gluconeogenesis, Humans, Insulin, Insulin Resistance, Liver, Receptor, Insulin, Signal Transduction, Lipogenesis, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.